Seoul Pharma Co. Ltd (018680) — Capital Reinvestment Ratio
Seoul Pharma Co. Ltd (018680) has a Capital Reinvestment Ratio of 0.04x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩2.07 Billion) in capital expenditures (₩89.75 Million). See Seoul Pharma Co. Ltd (018680) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Seoul Pharma Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks Seoul Pharma Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Check Seoul Pharma Co. Ltd (018680) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for Seoul Pharma Co. Ltd from 2009 to 2023. For live market cap and broader valuation context, see Seoul Pharma Co. Ltd (018680) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.36x | ₩5.26 Billion | ₩1.89 Billion | ▲ +207.5% |
| 2020 | 0.12x | ₩5.74 Billion | ₩671.25 Million | ▲ +119.1% |
| 2019 | 0.05x | ₩2.93 Billion | ₩156.43 Million | ▼ -94.6% |
| 2015 | 0.98x | ₩1.42 Billion | ₩1.40 Billion | ▼ -44.5% |
| 2014 | 1.77x | ₩1.48 Billion | ₩2.62 Billion | ▼ -9.0% |
| 2012 | 1.95x | ₩9.22 Billion | ₩17.95 Billion | ▲ +74.2% |
| 2011 | 1.12x | ₩4.86 Billion | ₩5.43 Billion | ▼ -77.4% |
| 2009 | 4.95x | ₩1.23 Billion | ₩6.11 Billion | — |